
Inogen INGN
$ 10.59
0.0%
Quarterly report 2024-Q3
added 11-08-2024
Country |
![]() |
IPO year |
2014 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Scott Wilkinson |
Employees in the company |
1 020 |
Shares |
23.2 M |
Market Cap[1] |
$ 245 M |
EBITDA (LTM) |
$ -59.8 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.